Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...
The Steelers Organized Team Activities (OTAs) are officially set to begin on May 27 and run through June 5. The following is ...
BeiGene is scrapping ociperlimab over a disappointing phase 3 outlook two years after Novartis handed back the anti-TIGIT ...
Topline Phase 2 clinical data expected in the first half 2025NEW YORK and MELBOURNE, Australia, April 03, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage ...
Tasman Therapeutics, Inc. (Tasman) has announced plans to raise $175 million in Series A funding to support the late-stage ...
BioMarin's Phase 3 trial shows Palynziq significantly reduces blood Phe in adolescents with PKU. The company plans a ...
Fundraising for Selby Gardens’ second of three master-planning expansion phases has passed the three-quarter mark with ...
OSHKOSH – The community was split down the middle on the Oshkosh Area School District’s facilities plan. The $197.8 million ...
Pembrolizumab plus concurrent chemoradiotherapy shows ongoing antitumor activity after about 5 years of follow-up in patients ...
Giant-cell arteritis is a systemic vasculitis with limited treatment options. The efficacy and safety of upadacitinib — a ...
DMRC's Phase 5 expansion will enhance connectivity across Delhi-NCR, strengthening the capital's transportation network., Delhi News News - Times Now ...
Oculis has significant longer-term potential. However, it remains a high-risk investment given its clinical stage status, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results